Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Hybrid Rapid Maxillary Expander Assisted With Microosteo Perforation Mops

Research Leaders

5 sponsors active, led by Celal Irgin

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed3
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Hybrid Rapid Maxillary Expander Assisted With Microosteo Perforation Mops1
  • A Locked Modified Acrylic Bonded Rapid Maxillary Expansion Appliance Arme1
  • Semirapid Maxillary Expansion Srme1
  • Dental Model Analysis1

Active Sponsors

  • Celal Irgin1
  • Fundación Universitaria CIEO1
  • Selcuk University1
  • Al-Azhar University1
  • TC Erciyes University1

Top Investigators

Related Conditions

  • Dental Malocclusion1
  • Crossbite Anterior Posterior1
  • Cross Bite1
  • Asymmetric Maxillary Arch Disorder1

Activity Timeline